Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
growth
MeSH D006128 - growth
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D048788:
Growth and development
2 Companies
2 Drugs
$
Success rate
D006128:
Growth
2 Companies
2 Drugs
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
BioPartners
Somatropin
Somatropin Biopartners
2013-08-05
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/3
Phase 2
0
%
0/0
Phase 3
60
%
3/5
Approved:
3
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
BioPartners
Somatropin
,
Somatropin pegol
Novo Nordisk
Somapacitan
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use